1)平田文郷:抗結核療法が奏功した網膜静脈周囲炎の1例.臨眼 55:603-606,2001
2)成田理会子:結核性ぶどう膜炎を疑った1症例.眼紀 56:193-196,2005
3)門脇雅子・下野信行・前原依子・他:視力低下を初発症状に診断された肺結核の1例.感染症学雑誌 82:381,2008
4)財団法人結核予防会:結核の統計,2009
5)Woods AC:Endogenous Inflammations of the Uveal Tract. 46-49, Williams & Wilkins, Baltimore, 1961
6)藤原久子:結核によるぶどう膜炎.増田寛次郎 宇山昌延・臼井正彦・他(編):ぶどう膜炎.166-174,医学書院,東京,1999
7)後藤 浩:結核性ぶどう膜炎の現状と診断,治療上の問題点.眼紀 52:461-467,2001
8)Keino H, Nakashima C, Watanabe T et al:Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol 37:595-601, 2009
9)後藤 浩:結核性ぶどう膜炎の最近の動向.あたらしい眼科 17:64-66,2000
10)湯浅武之助:結核.眼科診療プラクティス8(ぶどう膜炎診療のしかた):120-123,1993
11)Bansal R, Gupta A, Gupta V et al:Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis. Am J Ophthalmol 146:772-779, 2008
12)日本結核学会:結核診療ガイドライン,2009
13)Rosen PH, Spalton DJ, Graham M:Ocular tuberculosis. Eye 4:486-492, 1990
14)東出朋巳:抗VEGF抗体の眼科的臨床応用.6.血管新生緑内障.臨眼 50:1729-1737,2008
15)CDC:Guidelines for preventing the transmission of Mycobacterium tuberculosis in health care facilities, 1994. MMWR 43(RR-13):1-132, 1994
16)Tubach F, Salmon D, Ravaud P et al:Risk of tuberculosis is higher with anti-tumor factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy. The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 60:1884-1894, 2009